Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.7.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.123 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.123 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.27NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BQ.1.1.71NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.71NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21359South Korea
BA.2.12.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.12.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAJNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAJNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.431NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.431NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.168NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.168NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Q.6 (Alpha)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Q.6 (Alpha)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AZ.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.97NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.97NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CM.8.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.8.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBSNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBSNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BN.1.2.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.2.8NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAHNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAHNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.5.2.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBJ.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBJ.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.62NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.62NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.82NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.82NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.38.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.38.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.79.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.79.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XAFNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAFNWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BC.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BC.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.17.1 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used